CDH1 and sarcoma: The next large tumor categories with frequent E-Cadherin upregulation are papillary and clear cell RCCs derived from E-Cadherin negative proximal tubuli, melanocytic tumors, as well as several sarcoma types derived from E-Cadherin negative mesenchymal cells.